Novartis Investigative Site

Ishioka, Ibaraki 315-0037

0 studies enrolling now · 2 studies all time

What they study most

Branch Retinal Vein Occlusion, Diabetic Macular Edema

Studies at this site

• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema — Completed
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion — Stopped early